SCI Abstract

search
HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease
HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar dege...
HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease
HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar dege...
Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer’s disease
Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer’s disease
The accumulation of β-amyloid (Aβ) peptides into insoluble plaques is an early pathological feature of Alzheimer...
Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer’s disease
Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer’s disease
The accumulation of β-amyloid (Aβ) peptides into insoluble plaques is an early pathological feature of Alzheimer...
Are oligodendrocytes the missing link in Alzheimer’s disease and related dementia research?
Are oligodendrocytes the missing link in Alzheimer’s disease and related dementia research?
Auguste YSS, Ferro A, Kahng JA, Xavier AM, Dixon JR, Vrudhula U, et al. Oligodendrocyte precursor cells engulf synapses du...
Are oligodendrocytes the missing link in Alzheimer’s disease and related dementia research?
Are oligodendrocytes the missing link in Alzheimer’s disease and related dementia research?
Auguste YSS, Ferro A, Kahng JA, Xavier AM, Dixon JR, Vrudhula U, et al. Oligodendrocyte precursor cells engulf synapses du...
Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
The key pathological signature of ALS/ FTLD is the mis-localization of endogenous TDP-43 from the nucleus to the cytoplasm...
Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Tau is aberrantly acetylated in various neurodegenerative conditions, including Alzheimer’s disease, frontotemporal ...
The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells
The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells
Multiple sclerosis (MS) therapeutic goals have traditionally been dichotomized into two distinct avenues: immune-modulator...
Tau protein profiling in tauopathies: a human brain study
Tau protein profiling in tauopathies: a human brain study
Abnormal accumulation of misfolded and hyperphosphorylated tau protein in brain is the defining feature of several neurode...
APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12
APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12
Microglia are highly dynamic cells that play a critical role in tissue homeostasis through the surveillance of brain paren...
A partial Drp1 knockout improves autophagy flux independent of mitochondrial function
A partial Drp1 knockout improves autophagy flux independent of mitochondrial function
Dynamin-related protein 1 (Drp1) plays a critical role in mitochondrial dynamics. Partial inhibition of this protein is pr...
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Recent genetic studies on Alzheimer’s disease (AD) have brought microglia under the spotlight, as loci associated wi...
Alzheimer’s genes in microglia: a risk worth investigating
Alzheimer’s genes in microglia: a risk worth investigating
Despite expressing many key risk genes, the role of microglia in late-onset Alzheimer’s disease pathophysiology is s...
Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons
Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons
Progranulin (PGRN) is a lysosomal glycoprotein implicated in various neurodegenerative diseases, including frontotemporal ...
Altered plasma protein profiles in genetic FTD – a GENFI study
Altered plasma protein profiles in genetic FTD – a GENFI study
Plasma biomarkers reflecting the pathology of frontotemporal dementia would add significant value to clinical practice, to...
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Peptides and their mimetics are increasingly recognised as drug-like molecules, particularly for intracellular protein-pro...
Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies
Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies
The lack of effective therapies that slow the progression of Alzheimer’s disease (AD) and related tauopathies highli...
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease (PD)....